Affymax Says FDA Advisory Committee To Review Peginesatide - Quick Facts RTT News If approved, peginesatide will be the first once-monthly Erythropoiesis stimulating agent available for the treatment of anemia associated with chronic kidney disease patients on dialysis in the US. by RTT Staff Writer. Affymax Announces FDA Advisory Committee to Review Peginesatide MarketWatch (press release) FDA sets date to review Affymax anemia drug CNBC.com all 18 news articles »

...